GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

STBA · Mar 31, 2025

S&T BANCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000719220-25-000028Bank
Sequential deposit growth75thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.41% · CORE · VALID

Net-income growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

6.92% · CORE · VALID

Interest-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

-2.27% · CORE · VALID

Cash and equivalents20thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$211.8M · CORE · VALID

Sequential loan growth70thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.25% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History44 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
1.68%
Current
1.41%
Delta
-0.26%
Earnings Growth Increased
Previous
-9.34%
Current
6.92%
Delta
16.26%
Interest Income Growth Decreased
Previous
7.95%
Current
-2.27%
Delta
-10.22%
Liquidity Decreased
Previous
$244.8M
Current
$211.8M
Delta
-$33.0M
Loan Growth Increased
Previous
0.75%
Current
1.25%
Delta
0.51%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.